Skip to main content

Advertisement

SpringerLink
Log in

Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers

  • 2023 SAGES Oral
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

CDH1 gene mutations are the leading etiology of hereditary diffuse gastric cancer with cumulative lifetime risk ranging up to 83%. Prophylactic total gastrectomy (PTG) is, therefore, recommended for CDH1 carriers. A laparoscopic approach may reduce operative risk versus an open operation, thus leading more patients with CDH1 mutations to pursue PTG prior to cancer development. However, more experience and oncologic outcome data are needed for a laparoscopic approach and indicated lymphadenectomy.

Methods

A retrospective descriptive cohort study of adult patients with CDH1 mutations who underwent laparoscopic PTG with D1 lymphadenectomy between 2012 and 2022 was conducted at a single institution. All patients had preoperative EGD screening, and those with visible tumor lesions on surveillance EGD were excluded and not considered prophylactic. Demographics, family history, pathology, and operative course were obtained. Outcomes included complications, readmission, and postoperative weight change.

Results

Among 23 patients, median age was 48 years (IQR 37, 53) and 15 (65%) were female. Family history for gastric and/or lobular breast cancer was present in 22 (96%) patients. The median [IQR] time from positive genetic testing to PTG was 347 days [140, 625]. Pathologic evaluation showed five (22%) patients with foci of gastric cancer on pre-operative EGD biopsies, 10 (44%) in resected stomach specimens. All lymph nodes were negative. To address early postoperative complications, EJ anastomotic technique changed from EEA to GIA over the course of the study and feeding jejunostomy was no longer placed during PTG with minimal change in postoperative weight loss.

Conclusions

This is the largest series, spanning 10 years at a single institution, dedicated solely to a laparoscopic approach for risk-reducing PTG. A laparoscopic approach with limited lymphadenectomy resulted in acceptable surgical and oncologic outcomes. Despite no visible cancer, over half of our patients had foci of early gastric cancer. Therefore, CDH1 carriers should consider laparoscopic PTG.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Blair VR, McLeod M, Carneiro F, Coit DG, D’Addario JL, van Dieren JM, Harria KL, Hoogerbrugge N, Oliveira C, van der Post RS, Arnold J, Benusiglio PR, Bisseling TM, Boussioutas A, Cats A, Charlton A, Scheiber KEC, David JL, Pietro Md, Fitzgerald RC, Ford JM, Gamet K, Gulio I, Hardwick RH, Huntsman DG, Kaurah P, Kupfer SS, Latchford A, Mansfield PF, Nakajima T, Parry S, Rossaak J, Sugimura H, Svrcek M, Tischkowitz M, Ushijima T, Yamada H, Yang H, Claydon A, Figueiredo J, Paringatai K, Seruca R, Bougen-Zhukov N, Brew T, Busija S, Carneiro P, DeGregorio L, Fisher H, Gardner E, Godwin TD, Holm KN, Humar B, Lintott CJ, Monroe EC, Muller MD, Norero E, Nouri Y, Paredes J, Sanches JM, Schulpen E, Ribeiro AS, Sporle A, Whitworth J, Zhang L, Reeve AE, Guilford P (2020) Hereditary diffuse gastric cancer: updated clinical practice guidelines. Lancet Oncol 21(8):e386–e397

    Article  CAS  PubMed Central  Google Scholar 

  2. Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Filpin C, Nikkel S, Connolly-Wilson M, Weissman S, Rubinstein WS, Sebold C, Greenstein R, Stroop J, Yim D, Panzini B, McKinnon W, Greenblatt M, Wirtzfeld D, Fontaine D, Coit D, Yoon S, Chung D, Lauwers G, Pizzuti A, Vaccaro C, Redal MA, Oliveria C, Tischkoqitz M, Olschwang S, Gallinger S, Lynch H, Green J, Ford J, Pharoah P, Fernandez B, Huntsman D (2007) Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 297(21):2360

    Article  CAS  PubMed  Google Scholar 

  3. Laszkowska M, Silver ER, Schrope B, Kastrinos F, Wang TC, Hur C (2020) Optimal timing of total gastrectomy to prevent diffuse gastric cancer in individuals with pathogenic variants in CDH1. Clin Gastroenterol Hepatol 18(4):822–829.e4

    Article  Google Scholar 

  4. DiBrito SR, Blair AB, Prasath V, Habibi M, Harmon JW, Duncan MD (2020) Total gastrectomy for CDH-1 mutation carriers: an institutional experience. J Surg Res 247:438–444

    Article  CAS  PubMed  Google Scholar 

  5. Benesch MGK, Bursey SR, O’Connell AC, Ryan MG, Howard CL, Stockley CC, Mathieson A (2021) CDH1 gene mutation hereditary diffuse gastric cancer outcomes: analysis of a large cohort, systematic review of endoscopic surveillance, and secondary cancer risk postulation. Cancers 13(11):2622

    Article  CAS  PubMed Central  Google Scholar 

  6. Vos EL, Salo-Mullen EE, Tang LH, Schattner M, Yoon SS, Gerdes H, Markowitz AJ, Mandelker D, Janjigian Y, Offitt K, Coit DG, Stadler ZK, Strong VE (2020) Indications for total gastrectomy in CDH1 mutation carriers and outcomes of risk-reducing minimally invasive and open gastrectomies. JAMA Surg 155(11):1050

    Article  Google Scholar 

  7. Chen Y, Kingham K, Ford JM, Rosing J, Van Dam J, Jeffrey RB, Longacre TA, Chun N, Kurian A, Norton JA (2011) A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer. Ann Surg Oncol 18(9):2594–2598

    Article  PubMed  Google Scholar 

  8. Stillman MD, Kusche N, Toledano S, Hilfrank KJ, Yoon C, Gabre JT, Rustgi SD, Hur C, Kastrinos F, Ryeom SW, Yoon SS (2022) Short and long-term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene. J Surg Oncol 126(8):1413–1422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. McGarragle KM, Hart TL, Swallow C, Brar S, Govindarajan A, Cohen Z, Aronson M (2021) Barriers and facilitators to CDH1 carriers contemplating or undergoing prophylactic total gastrectomy. Fam Cancer 20(2):157–169

    Article  PubMed  Google Scholar 

  10. Strong VE, Gholami S, Shah MA, Tang LH, Janjigian YY, Schattner M, Selby LV, Yoon SS, Salo-Nullen E, Stadler ZK, Kelsen D, Brennan MF, Coit DG (2017) Total gastrectomy for hereditary diffuse gastric cancer at a single center: postsurgical outcomes in 41 patients. Ann Surg 266(6):1006–1012

    Article  PubMed  Google Scholar 

  11. Hebbard PC, MacMillan A, Huntsman D, Kaurah P, Carneiro F, Wen X, Kwan A, Boone D, Bursey F, Green J, Fernandez B, Fontaine D, Wirtzfeld DA (2009) Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the newfoundland experience with 23 patients. Ann Surg Oncol 16(7):1890–1895

    Article  CAS  PubMed  Google Scholar 

  12. Francis WP, Rodrigues DM, Perez NE, Lonardo F, Weaver D, Webber JD (2007) Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer. J Soc Laparoendosc Surg 11(1):142

    Google Scholar 

  13. Liu F, Huang C, Xu Z, Su X, Zhao G, Ye J, Du X, Huang H, Hu J, Li G, Yu P, Li Y, Suo J, Zhao N, Zhang W, Li H, He H, Sun Y (2020) Morbidity and mortality of laparoscopic vs open total gastrectomy for clinical stage I gastric cancer: the CLASS02 multicenter randomized clinical trial. JAMA Oncol 6(10):1590

    Article  PubMed  Google Scholar 

  14. van der Veen A, Brenkman HJF, Seesing MFJ, Haverkamp L, Luyer MDP, Niewenhuijzen GAP, Stoot JHMB, Tegels JJW, Wijnhoven BPL, Lagarde SM, de Steur WO, Hartgrink HH, Kouwenhoven EA, Wassenaar EB, Draaisma WA, van der Peet DL, May AM, Ruurda JP, van Hillegersberg R, LOGICA Study Group, Eligh AM, Ponten JEH, Heesakkers FBM, Hulsewe K, Tweed T, van Lanschot J, van Det MJ, van Duijvendijk P, van der Zaag ES, Broeders IA, van Berge Heneg MI, Wietse E, Daams F, Heineman DJ, van Laarhoven HW (2021) Laparoscopic versus open gastrectomy for gastric cancer (LOGICA): a multicenter randomized clinical trial. J Clin Oncol 39(9):978–989

    Article  Google Scholar 

  15. Li GZ, Doherty GM, Wang J (2022) Surgical management of gastric cancer. JAMA Surg 157(5):446–454

    Article  PubMed  Google Scholar 

  16. Pandalai PK, Lauwers GY, Chung DC, Patel D, Yoon SS (2011) Prophylactic total gastrectomy for individuals with germline CDH1 mutation. Surgery 149(3):347–355

    Article  PubMed  Google Scholar 

  17. Fink C, Baumann P, Wente MN, Knebel P, Bruckner T, Ulrich A, Werner J, Buchler MW, Diener MK (2013) Incisional hernia rate 3 years after midline laparotomy. Br J Surg 101(2):51–54

    Article  PubMed  Google Scholar 

  18. Diener MK, Voss S, Jensen K, Büchler MW, Seiler CM (2010) Elective midline laparotomy closure: the INLINE systematic review and meta-analysis. Ann Surg 251(5):843–856

    Article  PubMed  Google Scholar 

  19. Muir J, Aronson M, Esplen MJ, Pollett A, Swallow CJ (2016) Prophylactic total gastrectomy: a prospective cohort study of long-term impact on quality of life. J Gastrointest Surg 20(12):1950–1958

    Article  PubMed  Google Scholar 

  20. Milone M, Elmore U, Manigrasso M, Vertaldi S, Aprea G, Servillo G, Parise P, De Palma GD, Rosati R (2022) Circular versus linear stapling oesophagojejunostomy after laparoscopic total gastrectomy. A systematic review and meta-analysis. Am J Surg 223(5):884–892

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

None.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Surgery, University of Washington, 1959 NE Pacific St, Box 3564101, Seattle, WA, 98195, USA

    Mary K. Bryant, Rachel Sillcox & Brant K. Oelschlager

  2. Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, WA, USA

    William M. Grady

Authors
  1. Mary K. Bryant
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rachel Sillcox
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William M. Grady
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brant K. Oelschlager
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brant K. Oelschlager.

Ethics declarations

Disclosures

Mary K Bryant, Rachel Sillcox, William M Grady, Brant K Oelschlager declares no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 17 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bryant, M.K., Sillcox, R., Grady, W.M. et al. Laparoscopic prophylactic total gastrectomy with limited lymphadenectomy for CDH1 gene carriers. Surg Endosc 37, 9373–9380 (2023). https://doi.org/10.1007/s00464-023-10303-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-023-10303-7

Keywords

Search

Navigation